HCV-IN-29
CAS No. 1009119-83-8
HCV-IN-29 ( —— )
产品货号. M26245 CAS No. 1009119-83-8
HCV-IN-29 is a hepatitis C virus (HCV) inhibitor.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥405 | 有现货 |
|
10MG | ¥567 | 有现货 |
|
25MG | ¥923 | 有现货 |
|
50MG | ¥1353 | 有现货 |
|
100MG | ¥2009 | 有现货 |
|
500MG | ¥4334 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称HCV-IN-29
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述HCV-IN-29 is a hepatitis C virus (HCV) inhibitor.
-
产品描述HCV-IN-29 is a hepatitis C virus (HCV) inhibitor.
-
同义词——
-
通路Microbiology/Virology
-
靶点HCV
-
受体TRα; TRβ
-
研究领域——
-
适应症——
化学信息
-
CAS Number1009119-83-8
-
分子量570.4
-
分子式C26H32Cl4N6
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES[H][C@]1(CCCN1)C2=NC=C(C3=CC=C(C4=CC=C(C5=CN=C([C@]6([H])CCCN6)N5)C=C4)C=C3)N2.Cl.Cl.Cl.Cl
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Pennock GD, et al. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity. J Pharmacol Exp Ther. 1992 Oct;263(1):163-9.
产品手册
关联产品
-
Glecaprevir
Glecaprevir (ABT 493;A 1282576) is a novel HCV NS3/4A protease inhibitor with pan-genotypic activity, inhibits NS3/4A proteases from HCV genotypes 1-6 in vitro with IC50 of 3.5-11.3 nM.
-
SB-734117
SB-734117 inhibits productive replication of several HCMV strains. SB-734117 exhibited polypharmacology and was an inhibitor of several proteins from the AGC and CMCG kinase groups.
-
BLT-1
BLT-1 is a scavenger receptor BI (SR-BI)inhibitor.BLT-1 has IC50s of 60 and 110 nM for cellular DiI-HDL and [3H]CE-HDL uptake in ldlA[mSR-BI] cells.